Hospital-acquired candidaemia: Experience from a developing country

Journal of Hospital Infection

Volumn 35, Issue 2, 1997, Pages 141-147

  Al Soub, H ^a   Estinoso, W ^a  

^a HAMAD GENERAL HOSPITAL   (Qatar)

Author keywords

Candidaemia; Nosocomial infections; Risk factors

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA TROPICALIS; CANDIDIASIS; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; DEVELOPING COUNTRY; FEMALE; FUNGEMIA; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; MALE; MORTALITY; PARENTERAL NUTRITION; PRESCHOOL CHILD; QATAR; RISK FACTOR; SCHOOL CHILD;

EID: 0030942537     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(97)90102-X     Document Type: Article

References (21)

1. Body GP. Candidiasis in cancer patients. Am J Med 1984; 77 (Suppl. 4 D): 13-19.
2. Body GP, Bowlar R, Fainstan V. Infectious complication in leukaemia patients 1982. Semin Hematol 19: 193-198.
3. Jaravis, WR. The National Nosocomial Infections Surveillance System Hospital Infection Program (Center for Disease Control). Nosocomial fungal infection in the United States: National Nosocomial Infection Surveillance (NNIS) [abstract]. In: Proceeding of the 3rd International Conference on Nosocomial Infections, 1990,
4. Jarvis, WR. The National Nosocomial Infections Surveillance System Hospital Infection Program (Center for Disease Control). Predominant pathogens in hospital infection [abstract]. In: Proceeding of the 17th International Congress on chemotherapy, 1991.
5. Diamond, RD, Krzesicki R, Wellington J. Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J Clin Invest 1978, 61: 349-359.
6. Seelig, MS, Speth CP, Kozinn PJ, Taschdjian CL, Toni EF, Goldberg P. Patterns of Candida Endocarditis following cardiac surgery: importance of early diagnosis and therapy (an analysis of 91 cases). Prog Cardiovasc Dis 1974; 18: 125-160.
7. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial condidaemia: A case control study in adults without leukaemia. Am J Med 1989; 87: 614-620.
8. Solomkin JS, Floh AM, Simmons RL. Indication for therapy for fungaemia in postoperative patients. Arch Surg 1982, 117: 1272-1275.
9. Komshian, SV, Uwaydah AK, Sobwl JD, Crane LR. Fungaemia caused by Candida species and Torulopsis glabrata in the hospitalized patients: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989, 11: 379-390.
10. Meunier F, Aoun M, Bitar N. Candidaemia in immunocompromised patients. Clin Infect Dis 1992, 14: (suppl 1): S120-S125.
11. Dyess DL, Garrison RN, Fry DE. Candida sepsis: implication of polymicrobial bloodborne infection. Arch Surg 1985, 120: 345-348.
12. Harvey RL, Myers JP. Nosocomial fungemia in a large community hospital. Arch Intern Med 1988, 148: 2642-2645.
13. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungaemia in the immunocompromised host: changing patterns, antigenaemia, high mortality. Am J Med 1981, 71: 363-370.
14. Burchard, KW, Minor LB, Slotman GJ, Gann DS. Fungal sepsis in surgical patients. Arch Surg 1983; 118: 217-221.
15. Marsh PK, Tally FP, Kellum J, Callow A, Gorbach SL. Candida infection in surgical patients. Ann Surg 1983; 198: 42-47.
16. Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984; 77(Suppl. 4D): 20-27.
17. Horn R, Wong B, Kiehn TE, Armstrong D. Fungaemia in a cancer hospital: changing frequency, earlier onset, and result of therapy. Rev Infect Dis 1985, 7: 646-655.
18. Klein JJ, Watanakunakron C. Hospital-acquired fungaemia: its natural course and clinical significance. Am J Med 1979; 67: 51-58.
19. Edwards JE Jr, Filler SG. Current strategies for treating invasive candidiasis: emphisis on infections in non neutropenic patients. Clin Infect Dis 1992, 14(Suppl. 1); S106-S113.
20. Rex JH, Bennet JE, Sugar AM, et al. Fluconazole vs Amphotericin B for the treatment of candidaemia: results of a multicenter trial. Abstract. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agent and Chemotherapy, New Orleans, October 17-20, 1993. Washington, D.D.: American Society for Microbiology, 1993: 267.
21. Carlson E. Synergistic effect of candida and staphylococcus on mouse mortality. Infect Immun 1982; 38: 921-924.